Skip to main content

Recovery delayed as vaccine rollout still too slow

The vaccination rollout failed to accelerate markedly after the Golden Week holidays. This is entirely due to logistical challenges rather than insufficient vaccine supply, which should be resolved before long. But with the medical situation going from bad to worse, we suspect that any recovery in activity will be delayed towards the second half of Q3.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.